Tag: EMMA-CAN
Randomised data and technological advances fuel continued expansion of MMA embolisation
This advertorial, intended only for audiences outside the USA, is sponsored by Medtronic.
The presentation of data from multiple large, randomised clinical trials over the...
Canadian RCT joins growing list of studies demonstrating benefits with MMA embolisation...
The findings of EMMA-CAN—the first randomised controlled trial (RCT) in Canada assessing embolisation of the middle meningeal artery (EMMA) as an adjunct to surgical...
